Regentis Biomaterials Ltd. (RGNT) — Net Asset Momentum
Regentis Biomaterials Ltd. (RGNT) recorded a net asset momentum of 111.5% as of December 2025, with net assets of $4.74 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see Regentis Biomaterials Ltd. market cap and net worth.
YoY Momentum
Current Net Assets
Years of Data
Country
Regentis Biomaterials Ltd. Net Asset Momentum (2022–2025)
This chart tracks Regentis Biomaterials Ltd.'s year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +111.5%, with net assets of $4.74 Million USD as of December 2025. See RGNT equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Asset History for Regentis Biomaterials Ltd. (2022–2025)
The table below shows the complete annual net asset history for Regentis Biomaterials Ltd. from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check RGNT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $4.74 Million | $7.62 Million | $2.87 Million | ▲ +111.5% |
| 2024 | $-41.10 Million | $482.00K | $41.59 Million | ▲ +10.5% |
| 2023 | $-45.91 Million | $360.00K | $46.27 Million | ▼ -9.1% |
| 2022 | $-42.06 Million | $1.72 Million | $43.78 Million | — |